Boston Family Office LLC Abb Vie Inc. Transaction History

Boston Family Office LLC

  • $1.48 Billion
  • Q3 2024

A detailed history of Boston Family Office LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Boston Family Office LLC holds 74,821 shares of ABBV stock, worth $13.5 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares
74,821
Previous 74,866 0.06%
Holding current value
$13.5 Million
Previous $12.8 Million 15.07%
% of portfolio
1.0%
Previous 0.93%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$163.84 - $199.33 $7,372 - $8,969
-45 Reduced 0.06%
74,821 $14.8 Million
Q2 2024

Aug 12, 2024
SELL
$154.79 - $180.76 $384,188 - $448,646
-2,482 Reduced 3.21%
74,866 $12.8 Million
Q1 2024

May 13, 2024
SELL
$159.82 - $182.1 $317,881 - $362,196
-1,989 Reduced 2.51%
77,348 $14.1 Million
Q4 2023

Feb 12, 2024
SELL
$137.6 - $154.97 $155,625 - $175,271
-1,131 Reduced 1.41%
79,337 $12.3 Million
Q3 2023

Nov 13, 2023
SELL
$133.59 - $154.65 $12,824 - $14,846
-96 Reduced 0.12%
80,468 $12 Million
Q2 2023

Aug 14, 2023
SELL
$132.51 - $164.9 $320,144 - $398,398
-2,416 Reduced 2.91%
80,564 $10.9 Million
Q1 2023

May 10, 2023
SELL
$144.61 - $166.54 $177,147 - $204,011
-1,225 Reduced 1.45%
82,980 $13.2 Million
Q4 2022

Feb 07, 2023
SELL
$138.31 - $165.87 $9,820 - $11,776
-71 Reduced 0.08%
84,205 $13.6 Million
Q3 2022

Nov 08, 2022
SELL
$134.21 - $153.93 $482,082 - $552,916
-3,592 Reduced 4.09%
84,276 $11.3 Million
Q2 2022

Aug 11, 2022
SELL
$137.62 - $174.96 $236,981 - $301,281
-1,722 Reduced 1.92%
87,868 $13.5 Million
Q1 2022

May 11, 2022
BUY
$131.98 - $163.75 $434,874 - $539,556
3,295 Added 3.82%
89,590 $14.5 Million
Q4 2021

Feb 14, 2022
SELL
$107.43 - $135.93 $231,404 - $292,793
-2,154 Reduced 2.44%
86,295 $11.7 Million
Q3 2021

Nov 15, 2021
BUY
$106.4 - $120.78 $59,371 - $67,395
558 Added 0.63%
88,449 $9.54 Million
Q2 2021

Aug 12, 2021
SELL
$105.21 - $117.21 $219,678 - $244,734
-2,088 Reduced 2.32%
87,891 $9.9 Million
Q1 2021

May 07, 2021
SELL
$102.3 - $112.62 $45,523 - $50,115
-445 Reduced 0.49%
89,979 $9.75 Million
Q4 2020

Feb 16, 2021
BUY
$80.49 - $108.67 $492,840 - $665,386
6,123 Added 7.26%
90,424 $9.69 Million
Q3 2020

Nov 10, 2020
BUY
$85.91 - $100.83 $959,013 - $1.13 Million
11,163 Added 15.26%
84,301 $7.38 Million
Q2 2020

Aug 06, 2020
SELL
$73.37 - $98.18 $25,532 - $34,166
-348 Reduced 0.47%
73,138 $7.18 Million
Q1 2020

May 11, 2020
SELL
$64.5 - $97.79 $5,547 - $8,409
-86 Reduced 0.12%
73,486 $5.6 Million
Q4 2019

Feb 05, 2020
BUY
$72.13 - $90.25 $16,229 - $20,306
225 Added 0.31%
73,572 $6.51 Million
Q3 2019

Nov 12, 2019
SELL
$62.98 - $75.72 $26,766 - $32,181
-425 Reduced 0.58%
73,347 $5.55 Million
Q2 2019

Jul 30, 2019
SELL
$65.7 - $83.98 $78,248 - $100,020
-1,191 Reduced 1.59%
73,772 $5.37 Million
Q1 2019

May 09, 2019
SELL
$77.14 - $90.79 $105,373 - $124,019
-1,366 Reduced 1.79%
74,963 $6.04 Million
Q4 2018

Feb 12, 2019
SELL
$77.85 - $96.01 $715,441 - $882,331
-9,190 Reduced 10.75%
76,329 $7.04 Million
Q3 2018

Nov 01, 2018
SELL
$88.91 - $98.84 $126,963 - $141,143
-1,428 Reduced 1.64%
85,519 $8.09 Million
Q2 2018

Jul 26, 2018
SELL
$89.78 - $106.23 $67,514 - $79,884
-752 Reduced 0.86%
86,947 $8.06 Million
Q1 2018

Apr 30, 2018
SELL
$92.01 - $123.21 $272,165 - $364,455
-2,958 Reduced 3.26%
87,699 $8.3 Million
Q4 2017

Feb 06, 2018
SELL
$89.56 - $98.21 $256,410 - $281,175
-2,863 Reduced 3.06%
90,657 $8.77 Million
Q3 2017

Nov 13, 2017
BUY
$69.85 - $89.22 $6.53 Million - $8.34 Million
93,520
93,520 $8.31 Million

Others Institutions Holding ABBV

# of Institutions
3,853
Shares Held
1.25B
Call Options Held
16.8M
Put Options Held
12.2M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Boston Family Office LLC Portfolio

Follow Boston Family Office LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Family Office LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email